We have recently shown that CML cells constitutively express Hsp32 and that the disease-related oncoprotein BCR/ABL1 promotes expression of Hsp32 in Ba/F3 cells [28,29]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.